| Patents for C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718) |
|---|
| 06/21/2007 | US20070142386 New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1 |
| 06/21/2007 | US20070142352 Pteridinone Derivatives as Modulators of Chemokine Receptor Activity |
| 06/19/2007 | US7232824 Used for treating disorders with enhanced activity of transforming growth factor beta TGF- beta, kidney disorders associated with unregulated TGF- beta activity and excessive fibrosis including glomerulonephritis (GN), mesangial proliferative GN, immune GN, and crescentic GN |
| 06/14/2007 | US20070135505 Aralkyl ester soft drugs |
| 06/14/2007 | US20070134729 Novel antibacterial agents |
| 06/12/2007 | US7230101 Synthesis of methotrexate-containing heterodimeric molecules |
| 06/06/2007 | DE10051628B4 Einzelsträngiges Oligonukleotid und dessen Verwendung Single-stranded oligonucleotide and its use |
| 05/31/2007 | WO2007060404A1 PYRIDO-,PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
| 05/31/2007 | WO2002094185A3 Conjugates and compositions for cellular delivery |
| 05/31/2007 | CA2628920A1 Pyrido-,pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors |
| 05/30/2007 | EP1318814B1 Triazole compounds useful as protein kinase inhibitors |
| 05/23/2007 | EP1786819A1 Dihydropteridinone derivatives, methods for the production thereof and their use as medicaments |
| 05/23/2007 | EP1786818A1 Dihydropteridine derivatives, methods for their preparation and their use as drugs |
| 05/23/2007 | EP1786817A1 Pteridinones used as plk (polo like kinases) inhibitors |
| 05/22/2007 | CA2378852C Method for producing by stereospecific hydration tetrahydropterins and optically pure derivatives, in particular tetrahydrofolic acid and its optically pure derivatives |
| 05/22/2007 | CA2276694C New fatty acid derivatives |
| 05/16/2007 | EP1784406A1 Dihydropteridinones, process for their preparation and their use as drugs |
| 05/16/2007 | CN1962661A Folacin dimethylbiguanide and process for production thereof |
| 05/15/2007 | US7217716 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate NR2B antagonists |
| 05/10/2007 | US20070106041 Molecularly imprinted polymer obtainable by polymerization of hexamethyl phosphonamide based monomer in presence of a template molecule and extraction; crosslinking; separation of enantiomers, resolution, used for separation of enantiomers, diastereomers of the template molecule, separation of template |
| 05/10/2007 | US20070105865 Substituted bicyclic quinazolin-4-ylamine derivatives |
| 05/09/2007 | EP1599478B1 Dihydropteridinones, method for the production and use thereof in the form of drugs |
| 05/08/2007 | US7214688 Compounds |
| 05/03/2007 | WO2007049736A1 Concentration crystallizer and method |
| 05/02/2007 | EP1778691A1 Hydrates and polymorphs of 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl]amino]-3-methoxy-n-(1-methyl-4-piperidinyl)-benzamide, methods for the production thereof, and use thereof as medicaments |
| 05/01/2007 | US7211580 Compounds, compositions, and methods |
| 05/01/2007 | CA2188267C Use of tetrahydropteridine derivatives as no-synthase inhibitors |
| 05/01/2007 | CA2132131C 3-arylbenzofuranones as stabilisers |
| 04/26/2007 | WO2007020277A3 Condensed pyrimidine derivatives as inhibitors of foic acid-dependent enzymes |
| 04/25/2007 | EP1776364A2 Processes for preparing tetrahydrobiopterin, and analogs of tetrahydrobiopterin |
| 04/25/2007 | EP1776363A1 Novel 6-formyltetrahydropteridines method for production and use thereof as medicament against cancer amongst other things |
| 04/24/2007 | US7208557 Functional monomers for molecular recognition and catalysis |
| 04/17/2007 | US7205001 Anticancer agents; using potassium arsenite therapy and radiation |
| 04/17/2007 | CA2106882C Azaquinoxalines, processes for their preparation and their use |
| 04/12/2007 | WO2006104889A3 Novel compounds |
| 04/11/2007 | CN1946743A Hyaluronic acid/methotrexate compound |
| 04/04/2007 | CN1308329C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 03/29/2007 | WO2006101845A3 Synthesis and purification of pteroic acid and conjugates thereof |
| 03/28/2007 | EP1765820A1 Compounds and compositions as protein kinase inhibitors |
| 03/28/2007 | EP1443931B1 Ocular iontophoretic device for delivering methotrexate based medicaments and use thereof to treat neoplastic, angiogenic, fibroplastic, and/or immunosuppresive ocular irregularities |
| 03/28/2007 | EP0908182B2 Preventives or remedies for diseases induced by hypofunction of nitric oxide synthase (nos) |
| 03/27/2007 | US7196103 Indole derivatives as factor Xa inhibitors |
| 03/20/2007 | US7193082 Adding an organic acid to a non-alkaline suspension of (6S,6R)-5,6,7,8-tetraydrofolic acid, up to a pH value in the range of 1 to 3; heating the suspension from 30 degrees to 80 degrees C.; cooling the suspension from 20 degrees to 60 degrees C., with selective crystallization of the (6S)-isomer |
| 03/20/2007 | US7193080 Color photography |
| 03/14/2007 | EP1761536A1 Novel 2-benzylaminodihydropteridinones, method for producing them and use thereof as drugs |
| 03/08/2007 | WO2005049614A3 Processes for preparing tetrahydrobiopterin, and analogs of tetrahydrobiopterin |
| 03/08/2007 | US20070053831 Methods for binding agents to b-amyloid plaques |
| 03/06/2007 | CA2189131C Use of pteridine derivatives as no-synthase inhibitors |
| 03/01/2007 | US20070049600 Pteridinones as kinase inhibitors |
| 02/22/2007 | WO2007021234A1 Boron compounds useful in bnct |
| 02/22/2007 | US20070043000 Immunosuppresive effects of pteridine derivatives |
| 02/21/2007 | EP1754484A1 Condensed pyrimidine derivatives as inhibitors of foic acid-dependent enzymes |
| 02/20/2007 | US7179794 Antibiotics; bactericides |
| 02/20/2007 | US7179493 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 02/14/2007 | CN1911931A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 02/08/2007 | US20070032477 Pteridine derivatives useful for making pharmaceutical compositions |
| 01/30/2007 | US7169778 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents |
| 01/23/2007 | CA2239968C Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells |
| 01/18/2007 | WO2006058869A8 Substituted pteridines for treating inflammatory diseases |
| 01/18/2007 | WO2006058868A8 Substituted pteridines for treating inflammatory diseases |
| 01/18/2007 | WO2006056607A8 Substituted pteridines for treating inflammatory diseases |
| 01/16/2007 | US7164027 Aralkyl ester soft drugs |
| 01/16/2007 | US7163703 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 01/10/2007 | CN1894251A Crystalline forms of (6R)-l-erythro-tetrahydrobiopterin dihydrochloride |
| 01/09/2007 | US7160904 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 01/04/2007 | WO2007000648A1 Pharmaceutical formulations containing colostrum and calcium folinate for te treatment of disorders of the oral cavity |
| 01/04/2007 | US20070004721 Pteridine derivatives for the treatment of septic shock and tnf-a-related diseases |
| 01/03/2007 | EP1739097A1 Hyaluronic acid/methotrexate compound |
| 01/03/2007 | EP1328319B1 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
| 01/03/2007 | CN1890223A Capsaicin receptor agonists |
| 01/03/2007 | CN1292798C Ethylenedicysteine (EC)-drug conjugates |
| 12/28/2006 | US20060293335 Riboflavin derivative and its manufacture and uses |
| 12/26/2006 | US7153963 Phenylalanine derivatives |
| 12/21/2006 | US20060287314 2-amino-4-morpholino-6-(4-acetanilide)pteridine; 2-amino-4-morpholino-6-(4-benzoylaminophenyl)pteridine; 2-amino-4-morpholino-6-(4-methylsulfonylaminophenyl)pteridine; 2-amino-4-morpholino-6-[3-Boc-(L)-phenylalanine-aminophenyl]pteridine; immunosuppressive; transplant rejection; antiinflammatory |
| 12/20/2006 | EP1734044A1 Process for producing folic acid derivative |
| 12/20/2006 | CN1882560A Heterocompound and its production and usage method |
| 12/12/2006 | CA2378869C Method for making pure stereoisomers of tetrahydrofolic acid ester salts and tetrahydrofolic acid by fractionated crystallisation of tetrahydrofolic acid salts |
| 12/07/2006 | US20060276457 Piperazine-piperidines with CXCR3 antagonist activity |
| 11/28/2006 | CA2379640C Certain alkylene diamine-substituted heterocycles |
| 11/23/2006 | US20060264449 Compounds for modulation of kinesins as anticancer agents with administering |
| 11/22/2006 | EP1724287A1 Hyaluronic acid/methotrexate compound |
| 11/22/2006 | EP1723161A1 Radiolabeled compounds and compositions, their precursors and methods for their production |
| 11/22/2006 | EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors |
| 11/22/2006 | CN1285572C Cannabinod receptor ligands |
| 11/16/2006 | WO2006120251A1 Pteridines useful as hcv inhibitors and methods for the preparation thereof |
| 11/16/2006 | US20060258664 Method for the production of riboflavin of modification b/c in granular form |
| 11/16/2006 | US20060258658 Triazole compounds useful as protein kinase inhibitors |
| 11/16/2006 | CA2608326A1 Pteridines useful as hcv inhibitors and methods for the preparation thereof |
| 11/14/2006 | CA2244363C Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains |
| 11/08/2006 | CN1283641C Pteridine derivatives with nitric oxide synthase inhibitor function |
| 11/07/2006 | US7132116 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 11/07/2006 | CA2132132C Process for the preparation of 3-arylbenzofuranones |
| 11/02/2006 | EP1716149A2 Method for the production of crystalline (6rs)-n(5)-formyl-5,6,7,8-tetrahydrofolic acid |
| 11/01/2006 | CN1856499A New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1 |
| 10/31/2006 | CA2247419C Oxazole derivatives, their production and use |
| 10/26/2006 | WO2006112772A1 Combination product |
| 10/26/2006 | WO2006112495A1 Method for producing alpha form crystals of sapropterin hydrochloride |
| 10/26/2006 | WO2006058869A3 Substituted pteridines for treating inflammatory diseases |
| 10/26/2006 | WO2006058867A3 Substituted pteridines for the treatment of inflammatory diseases |
| 10/26/2006 | US20060240112 removal of DNA associated with riboflavin (vitamin B2) crystals; fermentation; precipitation; crystallization |